tiprankstipranks
Generate Biomedicines, Inc. (GENB)
NASDAQ:GENB
US Market
GENB
Generate Biomedicines, Inc.
RESEARCH TOOLSreports
Want to see GENB full AI Analyst Report?

Generate Biomedicines, Inc. (GENB) Financial Statements

87 Followers

Generate Biomedicines, Inc. Financial Overview

Generate Biomedicines, Inc.'s market cap is currently $1.98B. The company's EPS TTM is $; its P/E ratio is -3.26; Generate Biomedicines, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24
Income Statement
Total Revenue$ 31.89M$ 20.46M
Gross Profit$ 31.89M$ 20.46M
Operating Income$ -235.06M$ -196.94M
EBITDA$ -208.49M$ -163.71M
Net Income$ -203.15M$ -173.77M
Balance Sheet
Cash & Short-Term Investments$ 221.50M$ 393.63M
Total Assets$ 330.18M$ 518.26M
Total Debt$ 68.53M$ 76.97M
Net Debt$ -53.12M$ -99.30M
Total Liabilities$ 953.38M$ 953.35M
Stockholders' Equity$ -615.97M$ -434.52M
Cash Flow
Free Cash Flow$ -204.13M$ -121.20M
Operating Cash Flow$ -200.62M$ -117.75M
Investing Cash Flow$ 116.77M$ -57.73M
Financing Cash Flow$ 28.06M$ 91.33M
Currency in USD

Generate Biomedicines, Inc. Earnings and Revenue History

Income Statement >

Generate Biomedicines, Inc. Debt to Assets

Balance Sheet >

Generate Biomedicines, Inc. Cash Flow

Cash Flow >

Generate Biomedicines, Inc. Forecast EPS vs Actual EPS

Earnings >